Goldman Sachs Group »

Immuneering Corp - Class A shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Immuneering Corp - Class A (IMRX) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Immuneering Corp - Class A

Tip: Access up to 7 years of quarterly data

All positions including Immuneering Corp - Class A held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immuneering Corp - Class A by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.4M 457k 7.35
2023-09-30 $3.7M 483k 7.68
2023-06-30 $5.0M 489k 10.14
2023-03-31 $255k 26k 9.71
2022-12-31 $50k 10k 4.85
2022-06-30 $101k 19k 5.43
2022-03-31 $97k 15k 6.44
2021-12-31 $213k 13k 16.18